(Q39986644)

16 September 2017

Metformin, insulin, breast cancer and more... (English)

1 reference

16 September 2017

1 reference

Lev M Berstein

1

1 reference

PubMed ID

19374538

16 September 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

16 September 2017

1 reference

16 September 2017

5

1 reference

16 September 2017

3

1 reference

16 September 2017

309-312

1 reference

Insulin-lowering effects of metformin in women with early breast cancer

16 September 2017

1 reference

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer

21 January 2018

1 reference

Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease.

21 January 2018

1 reference

Metformin beyond diabetes: new life for an old drug

21 January 2018

1 reference

Metformin therapy and clinical uses

21 January 2018

1 reference

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

21 January 2018

1 reference

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

Cancer and aging: more puzzles, more promises?

21 January 2018

1 reference

Anti-inflammatory effects of insulin

21 January 2018

1 reference

Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.

21 January 2018

1 reference

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model

21 January 2018

1 reference

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model

21 January 2018

1 reference

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

21 January 2018

1 reference

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

21 January 2018

1 reference

Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview

21 January 2018

1 reference

Aromatase: biologic relevance of tissue-specific expression

21 January 2018

1 reference

Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer

21 January 2018

1 reference

Letrozole in the neoadjuvant setting: the P024 trial

21 January 2018

1 reference

Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

21 January 2018

1 reference

Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors

21 January 2018

1 reference

Pharmacogenetics of metformin response: a step in the path toward personalized medicine

21 January 2018

1 reference

Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.09.2

1 reference

16 September 2017

1 reference

PubMed ID

19374538